Overview

Kuros Biosciences develops and commercializes advanced bone graft solutions for bone healing and regeneration, primarily serving hospitals and clinics for spinal fusion and other orthopedic procedures. Its products, like MagnetOs and Fibrin PTH, use proprietary materials and formulations that actively influence the bone healing process to improve outcomes and lower the risk of non-unions. The company differentiates itself by focusing on a specialized niche within medical technology, validating effectiveness and safety through ongoing research, clinical trials, and partnerships that help bring targeted bone graft therapies to healthcare providers. Kuros’s goal is to enhance patient recovery and outcomes in bone-related surgeries while expanding access to proven graft-based healing solutions.